| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |